| Literature DB >> 35207468 |
Alec J Schmidt1, Yury García2, Diego Pinheiro3, Thomas A Reichert4, Miriam Nuño1.
Abstract
More than 40% of the deaths recorded in the first wave of the SARS-CoV-2 pandemic were linked to nursing homes. Not only are the residents of long-term care facilities (LTCFs) typically older and more susceptible to endemic infections, the facilities' high degree of connection to wider communities makes them especially vulnerable to local COVID-19 outbreaks. In 2008, in the wake of the SARS-CoV-1 and MERS epidemics and anticipating an influenza pandemic, we created a stochastic compartmental model to evaluate the deployment of non-pharmaceutical interventions (NPIs) in LTCFs during influenza epidemics. In that model, the most effective NPI by far was a staff schedule consisting of 5-day duty periods with onsite residence, followed by an 4-to-5 day off-duty period with a 3-day quarantine period just prior to the return to work. Unlike influenza, COVID-19 appears to have significant rates of pre-symptomatic transmission. In this study, we modified our prior modeling framework to include new parameters and a set of NPIs to identify and control the degree of pre-symptomatic transmission. We found that infections, deaths, hospitalizations, and ICU utilization were projected to be high and largely irreducible, even with rigorous application of all defined NPIs, unless pre-symptomatic carriers can be identified and isolated at high rates. We found that increasingly rigorous application of NPIs is likely to significantly decrease the peak of infections; but even with complete isolation of symptomatic persons, and a 50% reduction in silent transmission, the attack rate is projected to be nearly 95%.Entities:
Keywords: COVID-19; non-pharmaceutical interventions; nursing homes; pre-symptomatic carriers; silent transmission
Year: 2022 PMID: 35207468 PMCID: PMC8877375 DOI: 10.3390/life12020180
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729
Parameters and starting values for the model.
| Variables | Parameters | Values | References |
|---|---|---|---|
|
| Basic reproduction number | 2.0–4.0 | [ |
|
| Average latency period | 5.0 days | [ |
|
| Average recovery period for asymptomatic/symptomatic | 14 days | [ |
|
| Transmission reduction for social use of face mask | (1–0.146) | [ |
|
| Rate at which a symptomatic person requires hospitalization | 0.16/4 | [ |
|
| Rate at which a hospitalized person requires an ICU | 0.32/4 | [ |
|
| Average number of days a person remains hospitalized (in ward) | 1/11 | [ |
|
| Average days that a person stays in ICU | 1/12 | [ |
|
| Mortality rate in hospitalization | 0.15/11 | [ |
|
| ICU mortality rate | 0.33/12 | [ |
| Estimated | |||
| m | Fraction of exposed that progress to infection | 0.667 | |
|
| Probability of having asymptomatic escape monitoring efforts | 1 | |
|
| Transmission rate | ||
|
| Proportion of people who do not isolate themselves and continue to contribute to new infections | ||
| Epidemiological Classes | Initial Population Size | ||
| 50,000; 200; 27; 13; 8; 75 | |||
| 1; 0; 1; 0; 1; 0 | |||
|
| 1; 0; 1; 0; 1;0 | ||
|
| 0; 0 | ||
|
| 0; 0; | ||
|
| The subscripts | ||
Figure 1Attack rate, mortality rate, hospital and ICU admissions at 90% isolation.
Figure 2Detailed differences in attack rate for Category 5 scenarios over different isolation rates. Black lines represent the sensitivities of four rapid antigen tests approved by the FDA for detection of SARS-CoV-2 isolation rates higher than the test sensitivities are not achievable with the given test.
Means and CIs for the four main outcomes at isolation.
| Baseline | Category 1–2 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| 2.0 | (188, 190, 196) | (45, 48, 61) | (18, 21, 30) | (8, 10, 17) | (25, 28, 36) | (48, 57, 81) | (11, 15, 24) | (5, 7, 13) | (2, 3, 6) | (25, 28, 36) |
| 2.2 | (187, 190, 196) | (44, 48, 64) | (19, 22, 31) | (8, 10,18) | (25, 29, 36) | (54, 64, 86) | (13, 17 25) | (6, 8, 15) | (2, 4, 7) | (26, 28, 37) |
| 2.4 | (188, 190, 196) | (44, 49, 62) | (19, 22, 30) | (8, 10, 16) | (26, 28, 36) | (61, 71, 96) | (14, 18, 28) | (6, 8, 15) | (2, 3, 8) | (25, 28, 36) |
| 2.6 | (189, 190, 195) | (44, 48, 58) | (19, 22, 31) | (8, 10, 14) | (25, 29, 39) | (69, 77, 102) | (16, 20, 32) | (6, 9, 16) | (2, 4, 9) | (26, 28, 37) |
| 2.8 | (189, 191, 195) | (43, 47, 59) | (18, 21, 30) | (7, 9, 16) | (25, 28, 38) | (77, 85, 109) | (18, 22, 33) | (7, 10, 18) | (3, 4, 10) | (25, 28, 38) |
| 3.0 | (189, 190, 196) | (44, 47, 57) | (18, 21, 33) | (8, 10, 16) | (26, 28, 36) | (82, 93, 122) | (20, 24, 34) | (8, 11, 18) | ( 4, 5, 10) | (25, 28, 35) |
| 3.2 | (189, 191, 196) | (45, 48, 63) | (19, 22, 31) | (8, 9, 15) | (26, 29, 37) | (92, 101, 129) | (23, 26, 39) | (9, 12, 20) | (4, 5, 10) | (25, 28, 36) |
| 3.4 | (187, 190, 196) | (45, 49, 61) | (20, 22, 34) | (8, 10, 17) | (26, 29, 36) | (102, 111, 140) | (24, 28, 38) | (10, 12, 19) | (4, 6, 11) | (26, 29, 39) |
| 3.6 | (188, 190, 195) | (45, 48, 62) | (19, 22, 30) | (7, 10, 17) | (25, 28, 37) | (105, 113, 137) | (25, 29, 41) | (10, 13, 20) | (4, 6, 11) | (26, 29, 38) |
| 3.8 | (188, 190, 195) | (45, 49, 60) | (19, 22, 30) | (8, 10, 16) | (25, 28, 37) | (112, 120, 141) | (26, 30, 41) | (11, 14, 21) | (4, 6, 12) | (26, 29, 37) |
| 4.0 | (189, 191, 195) | (42, 47, 57) | (19, 22, 29) | (7, 9, 15) | (26, 29, 39) | (117, 125, 150) | (26, 31, 42) | (12, 14, 21) | (4, 6, 12) | (26, 29, 35) |
| Category 3–4 | Category 5 | |||||||||
|
| Epidemic Size | Hospitalization | ICU | Death | Staff | Epidemic Size | Hosp | ICU | Death | Staff |
| 2.0 | (30, 38, 62) | (7, 10, 17) | (3, 5, 10) | (1, 2, 5) | (40, 43, 54) | (22, 28, 46) | (5, 7, 13) | (2, 3, 7) | (1, 2, 4) | (39, 42, 50) |
| 2.2 | (38, 47, 71) | (9, 12, 21) | (4, 6, 12) | (1, 3, 6) | (39, 42, 49) | (24, 34, 58) | (6, 9, 18) | (2, 4, 9) | (1, 2, 5) | (39, 42, 52) |
| 2.4 | (44, 53, 84) | (10, 13, 21) | (4, 6, 11) | (1, 3, 6) | ( 40, 42, 52) | (27, 36, 54) | (6, 9, 17) | (2, 4, 10) | (1, 2, 6) | (39, 42, 51) |
| 2.6 | (50, 60, 87) | (12, 15, 24) | (5, 7, 14) | (2, 3, 8) | ( 40, 43, 50) | (32, 41, 71) | (8, 11, 20) | (3, 5, 10) | (1, 2, 6) | (38, 42, 51) |
| 2.8 | (57, 67, 96) | (14, 17, 27) | (5, 8, 15) | (2, 4, 9) | (40, 43, 51) | (39, 51, 80) | (8, 13, 25) | (3, 6, 14) | (1, 3, 7) | (39, 43, 51) |
| 3.0 | (58, 68, 98) | (14, 18, 28) | (6, 8, 14) | (2, 3, 8) | (40, 42, 52) | (48, 59, 97) | (11, 15, 26) | (5, 7, 15) | (2, 3, 9) | (39, 42, 51) |
| 3.2 | (69, 80, 110) | (16, 19, 30) | (7, 9, 14) | (2, 4, 8) | ( 40, 43, 51) | (49, 60, 97) | (10, 15, 25) | (5, 7, 12) | (2, 3, 7) | (39, 42, 52) |
| 3.4 | (73, 83, 112) | (17, 21, 35) | (7, 10, 19) | (3, 5, 10) | (39, 43, 51) | (50, 66, 100) | (13, 17, 28) | (5, 7, 15) | (2, 4, 8) | (39, 43, 55) |
| 3.6 | (83, 95, 130) | (20, 24, 35) | (9, 11, 18) | (3, 5, 9) | (40, 43, 51) | (63, 74.2, 111) | (15, 18, 30) | (6, 8, 15) | (2, 4, 8) | (40, 43, 52) |
| 3.8 | (86, 102, 142) | (21, 25, 36) | (9, 11, 19) | (3, 5, 11) | (39, 43, 52) | (68, 78, 110) | (16, 20, 35) | (7, 9, 16) | (3, 4, 10) | (40, 42, 51) |
| 4.0 | (97, 105, 134) | (24, 27, 40) | (10, 12, 18) | (4, 6, 11) | (40, 43, 52) | (77, 86, 118) | (17, 21, 36) | (7, 10, 18) | (2, 4, 8) | (40, 43, 52) |